Robert E Landry is EVP Finance CFO of REGENERON PHARMACEUTICALS, INC.. Currently has a direct ownership of 23,693 shares of REGN, which is worth approximately $16.4 Million. The most recent transaction as insider was on Jun 22, 2020, when has been sold 8,388 shares (Common Stock) at a price of $626.19 per share, resulting in proceeds of $5,252,481. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23.7K
0% 3M change
0% 12M change
Total Value Held $16.4 Million

Robert E Landry Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 22 2020
SELL
Payment of exercise price or tax liability
$5,252,481 $626.19 p/Share
8,388 Reduced 25.21%
24,885 Common Stock
Jun 22 2020
BUY
Exercise of conversion of derivative security
$4,945,463 $555.67 p/Share
8,900 Added 21.1%
33,273 Common Stock
Jun 11 2020
SELL
Open market or private sale
$608,202 $615.59 p/Share
988 Reduced 3.9%
24,373 Common Stock
Jun 10 2020
SELL
Payment of exercise price or tax liability
$1,532,772 $610.18 p/Share
2,512 Reduced 9.01%
25,361 Common Stock
Jun 10 2020
BUY
Exercise of conversion of derivative security
$954,450 $272.7 p/Share
3,500 Added 11.16%
27,873 Common Stock
Jun 09 2020
SELL
Open market or private sale
$2,590,062 $606.43 p/Share
4,271 Reduced 14.91%
24,373 Common Stock
Jun 08 2020
SELL
Payment of exercise price or tax liability
$6,652,284 $592.42 p/Share
11,229 Reduced 28.16%
28,644 Common Stock
Jun 08 2020
BUY
Exercise of conversion of derivative security
$4,226,850 $272.7 p/Share
15,500 Added 34.27%
29,730 Common Stock
Apr 20 2020
SELL
Open market or private sale
$1,845,317 $567.79 p/Share
3,250 Reduced 11.77%
24,373 Common Stock
Apr 17 2020
SELL
Open market or private sale
$550,421 $555.42 p/Share
991 Reduced 3.91%
24,373 Common Stock
Apr 17 2020
SELL
Payment of exercise price or tax liability
$5,141,335 $555.82 p/Share
9,250 Reduced 25.09%
27,623 Common Stock
Apr 17 2020
BUY
Exercise of conversion of derivative security
$3,408,750 $272.7 p/Share
12,500 Added 25.32%
36,873 Common Stock
Apr 16 2020
SELL
Payment of exercise price or tax liability
$1,594,138 $529.79 p/Share
3,009 Reduced 10.61%
25,364 Common Stock
Apr 16 2020
BUY
Exercise of conversion of derivative security
$1,090,800 $272.7 p/Share
4,000 Added 12.36%
28,373 Common Stock
Apr 15 2020
SELL
Open market or private sale
$443,312 $519.71 p/Share
853 Reduced 3.38%
24,373 Common Stock
Apr 14 2020
SELL
Payment of exercise price or tax liability
$1,380,278 $521.45 p/Share
2,647 Reduced 9.5%
25,226 Common Stock
Apr 14 2020
BUY
Exercise of conversion of derivative security
$954,450 $272.7 p/Share
3,500 Added 11.16%
27,873 Common Stock
Apr 13 2020
SELL
Open market or private sale
$422,238 $509.95 p/Share
828 Reduced 3.29%
24,373 Common Stock
Apr 09 2020
SELL
Payment of exercise price or tax liability
$1,358,044 $508.25 p/Share
2,672 Reduced 9.59%
25,201 Common Stock
Apr 09 2020
BUY
Exercise of conversion of derivative security
$954,450 $272.7 p/Share
3,500 Added 11.16%
27,873 Common Stock
Apr 07 2020
SELL
Open market or private sale
$348,104 $500.15 p/Share
696 Reduced 2.78%
24,373 Common Stock
Apr 06 2020
SELL
Payment of exercise price or tax liability
$1,151,884 $499.95 p/Share
2,304 Reduced 8.42%
25,069 Common Stock
Apr 06 2020
BUY
Exercise of conversion of derivative security
$818,100 $272.7 p/Share
3,000 Added 9.88%
27,373 Common Stock
Apr 03 2020
SELL
Open market or private sale
$337,982 $494.85 p/Share
683 Reduced 2.73%
24,373 Common Stock
Apr 02 2020
SELL
Open market or private sale
$610,334 $489.05 p/Share
1,248 Reduced 4.73%
25,161 Common Stock
REL

Robert E Landry

EVP Finance CFO
Tarrytown, NY

Track Institutional and Insider Activities on REGN

Follow REGENERON PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells REGN shares.

Notify only if

Insider Trading

Get notified when an Regeneron Pharmaceuticals, Inc. insider buys or sells REGN shares.

Notify only if

News

Receive news related to REGENERON PHARMACEUTICALS, INC.

Track Activities on REGN